Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Computer Models Help Explain How Tumors Evolve

By LabMedica International staff writers
Posted on 09 Sep 2015
Cancer researchers used computer modeling to create three-dimensional simulations of tumors developing over time in order to explain why the tumor mass is almost exclusively composed of one type of cell while a similar mass of normal tissue would be composed of many cell types.

Most cancers in humans are large, measuring centimeters in diameter, and composed of many billions of cells. More...
An equivalent mass of normal cells would be highly heterogeneous as a result of the mutations that occur during each cell division. What is remarkable about cancers is that virtually every cell within a large tumor often contains the same core set of genetic alterations, with heterogeneity confined to mutations that emerge late during tumor growth. How such alterations expand within the spatially constrained three-dimensional architecture of a tumor, and come to dominate a large, pre-existing lesion, has been unclear.

An international team of investigators from the University of Edinburgh (United Kingdom), Harvard University (Cambridge, MA, USA), and Johns Hopkins University (Baltimore, MD, USA) developed computer models to describe how short-range dispersal and cell turnover could account for rapid cell mixing inside the tumor during its evolution.

The investigators reported in the August 26, 2015, online edition of the journal Nature that a small selective advantage of a single cell within a large tumor would allow the descendants of that cell to replace the precursor mass in a clinically relevant time frame. They also demonstrated that the same mechanisms could be responsible for the rapid onset of resistance to chemotherapy.

The investigators stated that their model not only provided insights into spatial and temporal aspects of tumor growth, but also suggested that targeting short-range cellular migratory activity could have marked effects on tumor growth rates.

First author Dr. Bartlomiej Waclaw, a researcher in the school of physics and astronomy at the University of Edinburgh, said, "Computer modeling of cancer enables us to gain valuable insight into how this complex disease develops over time and in three dimensions."

Related Links:

University of Edinburgh
Harvard University
Johns Hopkins University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.